Responses
Poster Presentations
SLE, Sjögren's and APS - treatment
THU0306 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of The BCL-2 Inhibitor Venetoclax (ABT-199) in A Phase 1 Single and Multiple Ascending Dose Study in Female Patients with Systemic Lupus Erythematosus
Compose a Response to This Article
Other responses
No responses have been published for this article.